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ABSTRACT 
In this paper, a mathematical modeling concept is used to analyse the glucose-insulin interaction in managing Type 1 
Diabetes Mellitus (T1DM). The Hovorka model has been chosen to design the glucose kinetics, so that the relationship 
between reaction of insulin to blood glucose concentration can be observed. This mathematical model  implements a 
nonlinear ordinary differential equation where each parameter represents specific functions. The meal and exogenous insulin 
bolus are the two inputs in this mathematical model for prediction of glucose levels. The analysis of this model is done by 
using C++ programming language which is the first step towards system-on-chip (SoC) implementation for real time 
simulation based analysis of glucose-insulin dynamics. 
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INTRODUCTION 
According to International Diabetes Federation 
(IDF), in 2014, there are 385 millions of people worldwide 
suffering from diabetes which most of the numbers come 
from Western Pacific region such as Malaysia, China and 
Cambodia (Aguiree et al. 2013). This figure is expected to 
increase to 592 millions on 2035. Statistic of diabetes in 
Malaysia shows that 24,049 people died due to diabetes on 
2013 (Lum. 2015) and this make the diabetes prevalence in 
Malaysia is 15.2 % (Health 2011). The total money spent in 
this issue is almost RM 88.4 billion in 2013 (Lum. 2015). 
Diabetes can give effects to the economy, social and 
healthcare system since the population of the people 
suffering diabetes is high (Ajmera et al. 2013). 
Diabetes is a term used to describe the level of 
blood glucose concentration in the bloodstream. It is 
normally refer to high blood glucose level or also known as 
hyperglycemia. The glucose level can be high in the blood 
because there is insufficient amount of insulin produced by 
the pancreas. A quick action must be taken as the condition 
will get worse with time (Lum. 2015). If the glucose level is 
not tightly control, it will lead whether to hyperglycemia or 
hypoglycemia (low blood glucose level). 
There are four types of diabetes; Type 1 Diabetes 
Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM), 
Gestational Diabetes Mellitus (GDM) and other specific 
types (Gonzales and Adi, 2012). In this study, the focus is 
based on T1DM. Type 1 Diabetes Mellitus or known as 
insulin dependent is a condition where the pancreas unable 
to produce adequate amount of insulin to promote the 
uptake of glucose into the tissues. It may be due to 
destruction of β-cell in the pancreas. This type of diabetes 
normally experience by the children and young adult 
(Persatuan Diabetes Malaysia, 2006). People who is 
suffering TIDM must take insulin exogenously to prevent 
the level keep on increasing, so that the glucose 
concentration can be kept near to normaglycemic level (70 – 
140 mg/dL) (Soru et al., 2012). If the diabetes is poorly 
controlled, it can lead to long term complications such as 
retinopathy, nephropathy and cardiovascular pathologies. 
 Metabolic disease such as diabetes is the result of 
imbalance in glucose homeostasis (McKnight et al. 2013). 
A research on managing diabetes has been carried out since 
50 years ago especially towards using mathematical 
modeling (Bergman et al., 1981), (Chen and Tsai, 2010), 
(Cobelli et al., 2014), (Wilinska et al., 2005). The minimal 
model introduced by Bergmann (Bergman et al. 1979) has 
lead the advancement in managing diabetes and Hovorka 
(Hovorka et al., 2002) has improved the model by 
implementing compartmental model. Mathematical 
modeling is very useful because it can help the researcher to 
obtain knowledge on the glucose-insulin dynamic system, 
and to give a clear picture on how the glucose-insulin 
interaction works (Ajmera et al. 2013).  
By doing the simulation based analysis of the 
glucose-insulin dynamics, an optimum theraphy can be 
suggested to the diabetes patient, so that the blood glucose 
level concentration can be kept under controlled since any 
inaccuracy prescription of insulin dosage will lead to more 
serious problem (Yusof et al, 2014). Moreover, using a 
model predictive control (MPC) with the Hovorka model, 
the glucose concentration can be predicted by controlling 
the insulin pump based on the output of the Hovorka model 
(Pedersen and Hansen, 2010). The advantages of using 
MPC is that it is able to control nonlinear system (Wang et 
al., 2010) and has the ability in dealing with time delays 
(Jiang and Wang, 2010), however faster and longer time 
interval of computations for the prediction are needed. 
There is a microchip within the insulin pump that to carry 
out the computation however with a small capacity 
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(Naerum, 2010). Recently, towards low power and a 
compact system, a System-on-Chip (SoC) implementation 
based on field-programmable gate array (FPGA)  has 
gained much attention providing higher performance system 
when  compared to microcontroller-based architecture. The 
interconnection between the processor and the FPGA logic 
enables the system performance to be improved due to high-
bandwidth produced between them (Chen and Kung, 2008). 
Therefore, the aim of the research is to conduct a 
simulation based analysis for glucose-insulin reaction in 
Type 1 Diabetes Mellitus Patient using the Hovorka model 
as the first step before  System-on-Chip (SoC) 
implementation can be realized for a high performance real-
time system. The information on the amount of meal taken 
and the insulin bolus is taken into consideration to examine 
the effect on the glucose concentration in the bloodstream. 
The proposed FPGA-based SoC implementation and design 
process are also described in this paper to highlight the final 
target of this research work. 
This paper is organized into four sections; 
introduction, methodology, result and analysis and 
conclusion.  Section methodology discusses the method 
used to study the glucose-insulin reaction. All the equations 
involved in the Hovorka model is discussed in the section. 
In result and discussion section, the simulation results 
regarding the virtual type 1 diabetes mellitus with respect to 
meal disturbances and insulin bolus are presented and 
analyzed. The overall finding in this paper is concluded in 
the conclusion section. 
 
METHODOLOGY 
 
Hovorka Model 
 The Hovorka model (Hovorka et al., 2004), 
(Naerum, 2010), (Lassen and Nielsen, 2008), (Andersen, 
2014)  has been introduced by Dr Roman Hovorka who is a 
researcher in University of Cambridge under the 
Department of Paediatrics. His research focus is to develop 
a medical device that is the artificial pancreas to acquire the 
blood glucose level overnight by implementing 
mathematical modeling approach (Juvenile Diabetes 
Research Foundation).  The artificial pancreas can be 
described as a monitoring tool where it uses continuous 
glucose monitor to check the glucose level in every minute, 
so that the insulin pump can release adequate amount of 
insulin controlled by the control algorithm (Cambridge 
Immunology). 
 This model consists of three types of subsystems; 
glucose absorption subsystem, subcutaneous insulin 
absorption subsystem and insulin action subsystem. It 
includes eight nonlinear ordinary differential equations 
(ODE) that can be categorized as nonstiff equation (Boiroux 
et al., 2010).  
 
Subcutaneous Insulin Absorption Subsystem 
 The insulin is injected into a patient’s body 
through subcutaneous. This method is more practical 
because the insulin is given to the patient non-invasively 
compared to classical method injected directly to the 
bloodstream. The insulin absorption can be represented in 
equation as follows: 
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By knowing the amount of injected insulin, the rate of 
absorption of insulin into the bloodstream, UI(t) can be 
calculated as in equation (3). It is measured in mU/min. 
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As the insulin entered the bloodstream, it becomes the 
plasma insulin. The plasma insulin concentration, I(t) 
[mU/L] can be calculated by using the following formula. 
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S1(t)   : Amount of insulin in compartment 1, 
stomach [mU] 
S2(t)   : Amount of insulin in compartment 2, colon 
[mU] 
u(t)   : Insulin input [mU/min] 
s  : Time constant of injected insulin absorption 
[min] 
VI : Insulin distribution volume [L/kg] 
ke : Insulin elimination rate from plasma [min-1] 
 
Insulin Action Subsystem 
The relationship between insulin and glucose can 
be observed in insulin action subsystem. The input for this 
subsystem comes from the insulin absorption rate in the 
blood, UI(t).  It involves three parameter insulin dependent 
state; transport and distribution, x1(t), glucose disposal, x2(t)  
and endogenous production of glucose, x3(t). The 
nonlinearity of this model is due to these interactions and 
can be calculated by using the following formulas equation 
(5-7). 
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The relations between the activation rates, kb1, kb2 and 
kb3,the deactivation rates ka1, ka2 and ka3 and the insulin 
sensitivities SIT, SID and SIE are shown in equation (8-10). 
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ka1, ka2, ka3   : deactivation rate [min-1] 
kb1, kb2, kb3 : activation rate [min-1] 
SIT : insulin sensitivity of transport/ 
distribution [L/mU/min] 
SID : insulin sensitivity of disposal 
[L/mU/min] 
SIE : insulin sensitivity of EGP 
[L/mU/min]  
 
Carbohydrate (CHO) Absorption Subsystem 
In order to observe the effect of meal on the blood 
glucose concentration, additional subsystem has been 
included into the Hovorka model calledcarbohydrate (CHO) 
subsystem. It acts as the input to the model where it 
describes any uptake of meal. The function of this 
compartment is to know the glucose absorption rate, UG(t) 
[mmol/min] in the bloodstream when certain amount of 
carbohydrate is consumed, d(t) [g/min]. The equations 
involve in this subsystem are as follows: 
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Glucose Subsystem 
 This subsystem represents the amount of glucose 
in the bloodstream, Q1(t) [mmol] and in the peripheral tissue 
Q2(t) [mmol] from equation (15) and (16), respectively. 
When meal is consumed, carbohydrate content breakdown 
into glucose as it goes down into the stomach,  thus 
increasing the glucose concentration. An increase value in 
the glucose concentration will force the glucose to be 
distributed to nearby tissue that has low gradient of glucose 
concentration.  
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The blood glucose concentration measurement is an 
important parameter for people who is suffering diabetes. 
Therefore, it is important to know the blood glucose 
concentration, G(t) [mmol/L] before and after meal that can 
be calculated from Eq. 19. 
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UG(t) : Glucose absorption rate [mmol/min] 
F01,c : Consumption of glucose by the central 
nervous system [mmol/min/kg] 
FR : Renal glucose excretion [mmol/min] 
k12 : Glucose transfer rate from the blood to the 
tissue [min-1] 
EGP0 : EGP extrapolated to zero insulin 
concentration [mmol/min/kg] 
VG : Glucose distribution volume [L/kg] 
F01 : Non-insulin dependent glucose consumption 
[mmol/min/kg] 
 
Figure 1 shows the flow of each compartment in the 
Hovorka model. The first compartment which is CHO 
absorption will produce UG(t) which later use as the input 
for the gluco-regulatory system compartment. The output 
for the second compartment which is the subcutaneous 
insulin absorption is UI(t). This become the input for the 
insulin action subsystem. The third compartment which is 
the gluco-regulatory system compartment represents the 
glucose kinetics which shows the glucose distribution inside 
the body system. The final output of this model is the 
glucose concentration, G(t) and the plasma insulin 
concentration, I(t). For the constant parameters refer 
(Hovorka et al. 2004). 
 
Figure 1: The Hovorka model representation (Andersen, 
2014) 
 
D1(t)   : Amount of glucose in compartment 1, 
stomach [mmol] 
D2(t)   : Amount of glucose in compartment 2, colon 
[mmol] 
D(t)    : Ingested CHO input [mmol/min] 
AG(t) : CHO bioavailability 
MG(t) : Molecular weight of CHO [g/mol] 
d  : Time constant for glucose absorption rate 
[min] 
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Simulation Setup 
 In order to get a realistic view of the Hovorka 
model a number of different simulations are performed to 
examine how the blood glucose concentration reacts to meal 
disturbances according to insulin inputs. The simulations 
have been done using C++ language The ordinary 
differential equations (ODEs) of the Hovorka model are 
solved using forward Euler’s method with fixed step size of 
0.001. The initial value for every variable present in the 
equations is and is summarized in Table 1. The overall 
simulation is based on patient’s body weight (BW). In this 
simulation, the body weight is set constant to 70 kg because 
the body weight does not show significant changes when 
consumed certain amount of meal. 
 
Table 1: Initial value of each variable 
Variables Initial value 
D1(t) 0 
D2(t) 0 
S1(t) 3.6734 x 102 
S2(t) 3.6734 x 102 
I(t) 5.7616 
x1(t) 0.0295 
x2(t) 0.0047 
x3(t) 0.2996 
Q2(t) 23.3565 
Q1(t) 55.9971 
 
The C++ codes of the simulation will then be used for SoC 
implementation on FPGA to become the analysis-based tool 
in more interactive way. 
 
RESULT AND ANALYSIS 
 
Meal Simulation in Glucose-Insulin Reaction  
 The amount of meal taken can affect the blood 
glucose concentration. For diabetic person, they need to 
know how much carbohydrate they consumed, so that the 
amount of insulin administered can be effectively controlled 
the blood glucose concentration. This is to avoid a major 
problem that is hypoglycemia. 
By using the Hovorka model, simulations have 
been conducted to analyze the effect of meal disturbances 
and insulin inputs, u(t) that come from a constant basal 
insulin infusion rate, uba(t) as in equation (20) and insulin 
boluses, ubo(t) (Table 5) to the blood glucose concentration.  
 
BW*0954119.0)( tuba     (20) 
 
As shown in Table 2, a summary of daily meal 
intake has been constructed based on the amount of 
carbohydrate taken during breakfast, lunch, afternoon snack, 
dinner and evening snack. 
 
Table 2: Daily meal intake 
Meal Item Quantity CHO Content g CHO 
Breakfast 
 
 
 
Total 
Oatmeal 
Milk 
Dates 
Dried fruit 
2 cup 
1 cup 
4 units 
1 1/2 tbsp 
15g CHO per ½ cup 
15g CHO per 1 cup 
15g CHO per 3 units 
15 g CHO per 2 tbsp 
 
60.00 
15.00 
20.00 
11.25 
106.25 
Lunch 
 
 
 
Total 
Rice 
Carrot (cooked) 
Curry korma 
Honeydrew 
 
2/3 cup 
1/2 cup 
1/2 serving 
1 slice 
15g CHO per 1/3 cup 
5g CHO per 1/2 cup 
14g CHO per 1 serving 
15g CHO per 1 slice 
 
30.0 
5.0 
7.0 
15.0 
57.0 
Afternoon snack 
 
Total 
Sandwich crackers 
Raisin 
5 units 
1 tbsp 
15g CHO per 3 units 
15g CHO per 2 tbsp 
25.0 
7.5 
32.5 
Dinner 
 
 
 
Total 
Rice 
Fish fingers 
Banana 
Cabbage (cooked) 
1 cup 
3 unit 
1 unit 
1 cup 
15g CHO per 1/3 cup 
11g CHO per 2 units 
15g CHO per 1 unit 
5g CHO per 1/2 cup 
45.0 
16.5 
15.0 
10.0 
86.5 
Evening snack 
 
Total 
Sandwich crackers 
Raisin 
5 units 
1 tbsp 
15g CHO per 3 units 
15g CHO per 2 tbsp 
25.0 
7.5 
32.5 
 
Table 3 shows the starting time for each meal taken. Each 
meal consumed at different duration of time. For breakfast 
and snack it is estimated to finish the meal within 10 
minutes while for lunch and dinner it is approximately 20 
minutes each. The timing of each meal is important to note 
because it helps to calculate the rate of carbohydrate taken 
for each meal at the interval of five minutes which is 
according to a duration for a single bolus. the reason for five 
minutes intervals  is because at this interval the basal insulin  
 
infusion continuously supply to the virtual patient and blood 
glucose concentration is also measured every five minutes 
(Pejtersen and Jesen, 2010), (Skjaervold et al., 2012). The 
simulations are set to start at 6 o’clock in the morning.  
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Table 3: The time and duration of each meal 
Meal Starting time Duration (min) 
Breakfast 9:30 10 
Lunch 12:30 20 
Afternoon snack 16:00 10 
Dinner 18:30 20 
Evening Snack 21:00 10 
 
Table 4 shows the summary of bolus-like carbohydrate of 
each meal which based on the duration in Table 3. The 
information for total size, rate and bolus size are dependent 
to each other. The bolus size is the size of the meal when 
gathered as a single bolus. The rate and the bolus size can 
be calculated by referring to the following formula. 
 
duration
size total
  rate       (21) 
       
interval minute 5in   timeofnumber  * rate  size bolus   (22) 
 
Table 4: Bolus size for each meal 
Meal Total size 
(g) 
Rate 
(g/min) 
Bolus size 
(g/min) 
Breakfast 106.25 10.625 21.25 
Lunch 57.00 2.850 11.40 
Afternoon 
snack 
32.5 3.250 6.50 
Dinner 86.5 4.325 17.30 
Evening 
snack 
32.5 3.250 6.50 
 
According to the meal times and bolus sizes in the Tables 3 
and 4, respectively, the meal disturbances are represented in 
Figure 2. The timing of meal is measured in minutes. 
 
Figure 2: Meal disturbances with respect to time of meal. 
 
Figure 3 shows the result of the glucose concentration 
against time in response to the meal disturbances by 
considering only the basal insulin input that is computed to 
be 6.68 mU/min. The area within the two horizontal lines in 
light blue colour indicate the normal level of blood glucose 
concentration which in the range of 3.89 mmol/L to 7.77 
mmol/L (Soru et al., 2012). A person with glucose level 
concentration above or below this range will experience 
hypoglycemia or hyperglycemia, respectively. According to 
Figure 3, the blood glucose concentration seems very high 
when a meal is taken due to lack of amount of insulin 
produced by the pancreas to keep the blood glucose level 
within normal range.  
 
Figure 3: Glucose concentration against time by considering 
only the basal insulin. 
 
In order to control the glucose concentration level down to 
normal level after every meal, exogenous insulin inputs are 
added which are came from insulin infusion boluses in the 
simulations. These insulin boluses are found using trial and 
error in order to get the possible minimum level of glucose 
concentration while staying above hypoglycemia at 3.89 
mmol/L. Table 5 shows the rate of insulin boluses 
administration at five minute intervals which is also 
according to a duration for a single bolus. Here, the insulin 
bolus describes how one unit of insulin can affect on how 
much grams of carbohydrate.  
 
Table 5: Insulin boluses for the meals during a typical day 
found by trial and error 
Meal Insulin bolus, ubo(t) 
(mU/min) 
Breakfast 730 
Lunch 450 
Afternoon snack 250 
Dinner 650 
Evening snack 240 
 
The simulation is done according to three conditions such 
that an insulin bolus is administered at 30 minutes before, 
during and 30 minutes after each meal to observe the 
effectiveness of the insulin administration relative to the 
time of the meals. The amount of insulin administered on 
the three different time are the same. The insulin boluses 
together with basal insulin are represented in Figure 4. 
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Figure 4: Total insulin at each meal time. 
 
Figure 5 shows the simulation results of the glucose 
concentrations against time with bolus insulin administered 
according to the three simulation conditions. From the 
result, the level of blood glucose concentration keep on 
increasing and decreasing gradually for each meal time as 
the effect from the insulin boluses administration. 
Throughout the day, the blood glucose concentration is kept 
near to normal level but more stable and steady blood 
glucose levels are able to be controlled when the insulin 
bolus is given at 30 minutes before each of the meal time. 
Moreover, during the afternoon snack at time around 600 
min and 1100min, the blood glucose level reached the 
hypoglycemic state when the insulin bolus is administered 
during and 30 minutes after the meals. Thus, it shows that it 
is preferred to give insulin injection 30 minutes before meal 
time as it gives more steady reading of the blood glucose 
concentration and able to regulate the level within the 
normoglycemic range. 
Figure 5: Glucose concentration against time by considering 
the basal insulin and the insulin boluses administered 
before, during and after  each meal intake. 
 
Glucose-Insulin Reaction Design Work for SoC 
implementation 
 Field programmable gate array (FPGA) is a 
platform enable the circuit designer to configure their own 
digital logic blocks. The advantages of using FPGA are it 
can be used to provide real time simulation and 
configurable according to desired design requirements. 
SoC is an embedded system where the complete 
hardware system for a target application is integrated in a 
single chip (Hau et al. 2011) offering many benefits 
including lower hardware cost and power consumption. 
These benefits make SoC the best architecture for real time 
embedded systems having tight design constraints such as 
used in medical electronic devices.  
Based on the C++ simulation program developed 
in this study, the project will focus on the hardware design 
in which the high-level synthesis (HLS) approach will be 
used before further step is taken towards SoC 
implementation. A software Vivado HLS 2014.1 will be 
used to convert the C++ code into hardware description 
language (HDL) to enable the code implement into the 
FPGA board. This is known as hardware accelerator. 
Next, the design wll be furthered into designing the 
SoC platform using MicroBlaze soft processor core. The 
MicroBlaze intellectual property (IP) will be chosen. The 
synthesized IP package produced during the convertion into 
HDL code will be inserted into the SoC platform as one of 
the process required. Then, the process will undergo logic 
synthesis. The bitstream file will be generated to make 
possible the execution process into the FPGA board. Figure 
6 shows the overall process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The flow for SoC implementation 
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The proposed block diagram of glucose-insulin 
reaction analysis for SoC implementation is shown in 
Figure 7. The SoC will act as the virtual diabetes patient 
where it contains the Hovorka model that later will be used 
to do further analysis to get appropriate therapy for the 
patient. The virtual patient depends on three inputs; body 
weight, meal in terms of weight of carbohydrate and insulin 
bolus. Then, these information will be processed in the SoC 
to obtain the glucose concentration level and eventually 
could suggest the amount of insulin accurately to be taken 
by the patient.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Proposed block diagram for SoC implementation 
of real time glucose-insulin reaction. 
 
CONCLUSION 
According to the C++ programming used in this 
study, the blood glucose concentration has been analyzed 
based on the Hovorka model related to the effect of meal 
disturbances and insulin bolus. Later, this simulation-based 
analysis will be used for the SoC implementation to target 
for real time analysis system of glucose-insulin reaction. In 
the future, this type of SoC design work may have a 
potential to be further designed into a model predictive 
control of glucose-insulin for artificial pancreas system that 
act as a control system in regulating the glucose 
homeostasis in the bloodstream. 
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